CoChat

YAP promotes erlotinib resistance in human non-small cell lung cancer cells

Open access
Hsu, Ping-Chih, You, Bin, Yang, Yi-Lin, Zhang, Wen-Qian, Wang, Yu-Cheng, Xu, Zhidong, Dai, Yuyuan, Liu, Shu, Yang, Cheng-Ta, Li, Hui, Hu, Bin, Jablons, David M., You, Liang · 2016 · Oncotarget
Cited by 119

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Ping-Chih Hsu 1, 2, * , Bin You 1, 3, * , Yi-Lin Yang 1 , Wen-Qian Zhang 1, 3 , Yu-Cheng Wang 1 , Zhidong Xu 1 , Yuyuan Dai 1 , Shu Liu 1 , Cheng-Ta Yang 2 , Hui Li 3 , Bin Hu 3 , David M. Jablons 1 , Liang You 1 1 Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA, USA 2 Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan 3 Department of Thoracic Surgery, Beijing Chao-Yang Hospital, Affiliated with Capital University of Medical Science, Beijing, People’s Republic of China * These authors have contributed equally to this work Correspondence to: Liang You, email: Liang.you@ucsfmedctr.org Keywords: Hippo pathway, yes-associated protein, epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance, erlotinib, non-small cell lung cancer Received: September 28, 2015 Accepted: June 17, 2016 Published: July 07, 2016 ABSTRACT Yes-associated protein (YAP) is a main mediator of the Hippo pathway, which promotes cancer development. Here we show that YAP promotes resistance to erlotinib in human non-small cell lung cancer (NSCLC) cells. We found that forced YAP overexpression through YAP plasmid transfection promotes erlotinib resistance in HCC827 (exon 19 deletion) cells. In YAP plasmid-transfected HCC827 cells, GTIIC reporter activity and Hippo downstream gene expression of AREG and CTGF increased significantly (P<0.05), as did ERBB3 mRNA expression (P<0.05). GTIIC reporter activity, ERBB3 protein and mRNA expression all increased in HCC827 erlotinib-resistance (ER) cells compared to parental HCC827 cells. Inhibition of YAP by small interfering RNA (siRNA) increased the cytotoxicity of erlotinib to H1975 (L858R+T790M) cells. In YAP siRNA-transfected H1975 cells, GTIIC reporter activity and downstream gene expression of AREG and CTGF decreased significantly (P<0.05). Verteporfin, YAP inhibitor had an effect similar to that of YAP siRNA; it increased sensitivity of H1975 cells to erlotinib and in combination with erlotinib, synergistically reduced migration, invasion and tumor sphere formation abilities in H1975 cells. Our results indicate that YAP promotes erlotinib resistance in the erlotinib-sensitive NSCLC cell line HCC827. Inhibition of YAP by siRNA increases sensitivity of erlotinib-resistant NSCLC cell line H1975 to erlotinib.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.10458

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 119

Metadata

Authors
Hsu, P.-C., You, B., Yang, Y.-L., Zhang, W.-Q., Wang, Y.-C., Xu, Z., Dai, Y., Liu, S., Yang, C.-T., Li, H., Hu, B., Jablons, D. M., & You, L.
Venue
Oncotarget
Published
2016-07-07
Volume
7
Issue
32
Pages
51922-51933
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2468906605
Cited by
119
References
12
FWCI
10.17
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: YAP promotes erlotinib resistance in human non-small cell lung cancer cells. https://app.cochat.ai/papers/10.18632/oncotarget.10458
The paper
Hsu, P.-C., You, B., Yang, Y.-L., Zhang, W.-Q., Wang, Y.-C., Xu, Z., Dai, Y., Liu, S., Yang, C.-T., Li, H., Hu, B., Jablons, D. M., & You, L. (2016). YAP promotes erlotinib resistance in human non-small cell lung cancer cells. Oncotarget. https://doi.org/10.18632/oncotarget.10458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.